Total submissions: 20
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000246334 | SCV000209598 | benign | not specified | 2013-10-15 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Prevention |
RCV000246334 | SCV000301661 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Illumina Laboratory Services, |
RCV000282415 | SCV000367044 | likely benign | Ataxia-telangiectasia syndrome | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Laboratory for Molecular Medicine, |
RCV000246334 | SCV000538364 | benign | not specified | 2016-03-28 | criteria provided, single submitter | clinical testing | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency |
Color Diagnostics, |
RCV000579796 | SCV000682113 | benign | Hereditary cancer-predisposing syndrome | 2015-03-31 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV000282415 | SCV000743725 | likely benign | Ataxia-telangiectasia syndrome | 2014-10-09 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000246334 | SCV000840932 | benign | not specified | 2017-05-16 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000282415 | SCV001000292 | benign | Ataxia-telangiectasia syndrome | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000282415 | SCV001775306 | benign | Ataxia-telangiectasia syndrome | 2021-07-14 | criteria provided, single submitter | clinical testing | |
Institute for Clinical Genetics, |
RCV001795282 | SCV002010830 | likely benign | not provided | 2021-11-03 | criteria provided, single submitter | clinical testing | |
National Health Laboratory Service, |
RCV002225460 | SCV002505345 | benign | Hereditary breast ovarian cancer syndrome | 2022-04-19 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000579796 | SCV002611545 | benign | Hereditary cancer-predisposing syndrome | 2015-05-12 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
ARUP Laboratories, |
RCV001795282 | SCV004564627 | benign | not provided | 2023-11-16 | criteria provided, single submitter | clinical testing | |
Myriad Genetics, |
RCV004589663 | SCV005083895 | benign | Familial cancer of breast | 2024-05-14 | criteria provided, single submitter | clinical testing | This variant is considered benign. This variant is intronic and is not expected to impact mRNA splicing. This variant has been observed at a population frequency that is significantly greater than expected given the associated disease prevalence and penetrance. |
Diagnostic Laboratory, |
RCV000246334 | SCV001740347 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000246334 | SCV001808103 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics Laboratory, |
RCV000246334 | SCV001905936 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV000246334 | SCV001924295 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000246334 | SCV001954679 | benign | not specified | no assertion criteria provided | clinical testing | ||
Laboratory of Diagnostic Genome Analysis, |
RCV001795282 | SCV002035499 | likely benign | not provided | no assertion criteria provided | clinical testing |